- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Strides Pharma's subsidiary is acquiring Sandoz's branded generics portfolio in Sub-Saharan Africa for US$12 million. This move more than doubles its regional presence, aiming for a top-five market position and is expected to be EPS-accretive, strengthening its Africa business.